Featured Research

from universities, journals, and other organizations

Budesonide Provides Lasting Relief For Crohn's Disease Patients

Date:
September 13, 2005
Source:
Blackwell Publishing Ltd.
Summary:
In a study published in The American Journal of Gastroenterology, researchers found that budesonide capsules are an effective treatment to prolong and maintain the period of remission of Crohn's disease. Previous studies have demonstrated that budesonide is effective for inducing remission of Crohn's disease.

In a study published in The American Journal of Gastroenterology,researchers found that budesonide capsules are an effective treatmentto prolong and maintain the period of remission of Crohn's Disease.Previous studies have demonstrated that budesonide is effective forinducing remission of Crohn's disease.

Four double-blind, placebo-controlled trials were conducted withidentical protocols in which patients with Crohn's Disease, andmedically induced remission, received a treatment of oral budesonidefor 12 months. Results showed that budesonide taken at 6 mg/day iseffective for prolonging time to relapse and for significantly reducingrates of relapse.

"Long-term treatment with budesonide is well-tolerated and thefrequency and types of adverse events are similar to placebo," stateslead researcher,William J. Sandborn, MD. "Safety of a long-termmedication is obviously important, but how well a patient toleratestheir medication is also important and can affect patient adherence totherapy."

Crohn's disease is a long-term disease that results from inflammationof the digestive tract. It is a debilitating sickness, even forpatients who are classified as having mild to moderate disease.Currently, there are no treatment options available that preventsrecurrence of symptoms.

"As stated, this disease is recurring in nature, so extending the timea patient can be symptom-free or with diminished symptoms is animportant feature of treatment. Budesonide capsules are a treatmentoption for Crohn's disease that has been shown in studies not only tobe very effective in relieving symptoms, but also in extending the timebefore patients experience a recurrence."

###

This study is published in The American Journal of Gastroenterology.

Dr.William J. Sandborn is a board certified gastroenterologist withspecific expertise in inflammatory bowel disease. He has publishedextensively in this field, both nationally and internationally.

About The American Journal of Gastroenterology
The American Journal of Gastroenterology, the official publication ofthe American College of Gastroenterology, is THE clinical journal forall practicing gastroenterologists, hepatologists and GI endoscopists.With an impact factor of 4.716, it is the authoritative clinical sourcein the field of gastroenterology. With a broad-based, rigorous,interdisciplinary approach, the journal presents the latest importantinformation in the field of gastroenterology including originalmanuscripts, meta-analyses and reviews, health economic papers, debatesand consensus statements of clinical relevance in gastroenterology. Thereports will highlight new observations and original research, resultswith innovative treatments and all other topics relevant to clinicalgastroenterology. Case reports highlighting disease mechanisms orparticularly important clinical observations and letters on articlespublished in the Journal are included.

About Blackwell Publishing
Blackwell Publishing is theworld's leading society publisher, partnering with more than 600academic and professional societies. Blackwell publishes over 750journals annually and, to date has published close to 6,000 text andreference books, across a wide range of academic, medical, andprofessional subjects.


Story Source:

The above story is based on materials provided by Blackwell Publishing Ltd.. Note: Materials may be edited for content and length.


Cite This Page:

Blackwell Publishing Ltd.. "Budesonide Provides Lasting Relief For Crohn's Disease Patients." ScienceDaily. ScienceDaily, 13 September 2005. <www.sciencedaily.com/releases/2005/09/050913123928.htm>.
Blackwell Publishing Ltd.. (2005, September 13). Budesonide Provides Lasting Relief For Crohn's Disease Patients. ScienceDaily. Retrieved October 20, 2014 from www.sciencedaily.com/releases/2005/09/050913123928.htm
Blackwell Publishing Ltd.. "Budesonide Provides Lasting Relief For Crohn's Disease Patients." ScienceDaily. www.sciencedaily.com/releases/2005/09/050913123928.htm (accessed October 20, 2014).

Share This



More Health & Medicine News

Monday, October 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

How Nigeria Beat Its Ebola Outbreak

How Nigeria Beat Its Ebola Outbreak

Newsy (Oct. 20, 2014) The World Health Organization has declared Nigeria free of Ebola. Health experts credit a bit of luck and the government's initial response. Video provided by Newsy
Powered by NewsLook.com
Another Study Suggests Viagra Is Good For The Heart

Another Study Suggests Viagra Is Good For The Heart

Newsy (Oct. 20, 2014) An ingredient in erectile-dysfunction medications such as Viagra could improve heart function. Perhaps not surprising, given Viagra's history. Video provided by Newsy
Powered by NewsLook.com
Ebola Worries End for Dozens on U.S. Watch Lists

Ebola Worries End for Dozens on U.S. Watch Lists

Reuters - US Online Video (Oct. 20, 2014) Forty-three people who had contact with Thomas Eric Duncan, the first person diagnosed with Ebola in the U.S., were cleared overnight of twice-daily monitoring after 21 days of showing no symptoms. Rough Cut (no reporter narration). Video provided by Reuters
Powered by NewsLook.com
CDC Calls for New Ebola Safety Guidelines

CDC Calls for New Ebola Safety Guidelines

AP (Oct. 20, 2014) Centers for Disease Control and Prevention Director Dr. Tom Frieden laid out new guidelines for health care workers when dealing with the deadly Ebola virus including new precautions when taking off personal protective equipment. (Oct. 20) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins